Put Options

20 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $216 Million - $236 Million
698,800 New
698,800 $225 Million
Q1 2022

May 17, 2022

BUY
$219.27 - $242.57 $342 Million - $378 Million
1,557,900 Added 876.21%
1,735,700 $420 Million
Q4 2021

Feb 15, 2022

SELL
$198.88 - $227.6 $2.9 Million - $3.32 Million
-14,600 Reduced 7.59%
177,800 $40 Million
Q3 2021

Nov 16, 2021

BUY
$212.27 - $248.7 $23.2 Million - $27.2 Million
109,200 Added 131.25%
192,400 $40.9 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $1.52 Million - $1.68 Million
-6,500 Reduced 7.25%
83,200 $20.3 Million
Q1 2021

May 18, 2021

SELL
$221.91 - $258.6 $2.86 Million - $3.34 Million
-12,900 Reduced 12.57%
89,700 $22.3 Million
Q4 2020

Feb 17, 2021

SELL
$216.38 - $257.67 $3.7 Million - $4.41 Million
-17,100 Reduced 14.29%
102,600 $23.6 Million
Q3 2020

Nov 17, 2020

BUY
$234.65 - $260.95 $11.6 Million - $12.9 Million
49,400 Added 70.27%
119,700 $30.4 Million
Q2 2020

Aug 17, 2020

BUY
$197.81 - $242.74 $751,678 - $922,412
3,800 Added 5.71%
70,300 $16.6 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $19.2 Million - $25.4 Million
-105,100 Reduced 61.25%
66,500 $13.5 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $22.1 Million - $28.4 Million
116,700 Added 212.57%
171,600 $41.4 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $52,233 - $62,586
-300 Reduced 0.54%
54,900 $10.6 Million
Q2 2019

Aug 15, 2019

SELL
$166.7 - $195.41 $3.35 Million - $3.93 Million
-20,100 Reduced 26.69%
55,200 $10.2 Million
Q1 2019

May 16, 2019

BUY
$180.87 - $203.88 $5.52 Million - $6.22 Million
30,500 Added 68.08%
75,300 $14.3 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $196,240 - $229,075
1,100 Added 2.52%
44,800 $8.72 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $2.08 Million - $2.34 Million
11,200 Added 34.46%
43,700 $9.06 Million
Q2 2018

Aug 15, 2018

SELL
$166.05 - $186.51 $780,435 - $876,597
-4,700 Reduced 12.63%
32,500 $6 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $1.75 Million - $2.04 Million
-10,300 Reduced 21.68%
37,200 $6.34 Million
Q4 2017

Feb 15, 2018

SELL
$168.79 - $188.59 $20 Million - $22.3 Million
-118,200 Reduced 71.33%
47,500 $8.26 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $27.7 Million - $31.6 Million
165,700
165,700 $30.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.